VTYX FY 2021 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

VTYXVentyx Biosciences, Inc.

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$67M

Net Income

-$84M

EPS (Diluted)

$-1.69

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$39M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$291M

Total Liabilities

$12M

Stockholders' Equity

$279M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$67M	-$7M	-852.4%
Net Income	-$84M	-$28M	-197.2%